title: Controlled cord traction for the third stage of labour.
abstract: BACKGROUND
  Active management of the third stage of labour (AMTSL) consists of a group of interventions, including administration of a prophylactic uterotonic (at at or after delivery of the baby), baby, cord clamping and cutting, controlled cord traction (CCT) to deliver the placenta, and uterine massage. Recent recommendations are to delay cord clamping until the caregiver is ready to initiate CCT. The package of AMTSL reduces the risk of postpartum haemorrhage, (PPH), as does one component, routine use of uterotonics. The contribution, if any, of CCT needs to be quantified, as it is uncomfortable, and women may prefer a 'hands-off' approach. In addition its implementation has resource implications in terms of training of healthcare providers.
  
  
  OBJECTIVE
  To evaluate the effects of controlled cord traction during the third stage of labour, either with or without conventional active management.
  
  
  METHODS
  We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (29 January 2014), PubMed (1966 to 29 January 2014), and reference lists of retrieved studies.
  
  
  METHODS
  Randomised controlled trials comparing planned CCT versus no planned CCT in women giving birth vaginally.
  
  
  METHODS
  Two authors assessed trial quality and extracted data using a standard data extraction form.
  
  
  RESULTS
  We included three methodologically sound trials with data on 199, 4058 and 23,616 women respectively. Blinding was not possible, but bias could be limited by the fact that blood loss was measured objectively.There was no difference in the risk of blood loss ≥ 1000 mL (three trials, 27,454 women; risk ratio (RR) 0.91, 95% confidence interval (CI) 0.77 to 1.08). Manual removal of the placenta was reduced with CCT (two trials, 27,665 women; RR 0.69, 95% CI 0.57 to 0.83). In the World Health Organization (WHO) trial the reduction in manual removal occurred mainly in sites where ergometrine was used routinely in the third stage of labour. The non-prespecified analysis excluding sites routinely using ergometrine for management of the third stage of labour found no difference in the risk of manual removal of the placenta in the WHO trial (one trial, 23,010 women; RR 1.03, 95% CI 0.73 to 1.46). The policy of restricting the third stage of labour to 30 minutes (4057 women; RR 0.69, 95% CI 0.53 to 0.90) may have had an effect in the French study.Among the secondary outcomes, there were reductions in blood loss ≥ 500 mL (three trials, 27,454 women; RR 0.93, 95% CI 0.88 to 0.99), mean blood loss (two trials, 27,255 women; mean difference (MD) -10.85 mL, 95% CI -16.73 to -4.98), and duration of the third stage of labour (two trials, 27,360 women; standardised MD -0.57, -0.59 to -0.54). There were no clear differences in use of additional uterotonics (three trials, 27,829 women; average RR 0.95, 95% CI 0.88 to 1.02), blood transfusion, maternal death/severe morbidity, operative procedures nor maternal satisfaction. Maternal pain (non-prespecified) was reduced in one trial (3760 women; RR 0.78, 95% CI 0.61 to 0.99).The following secondary outcomes were not reported upon in any of the trials: retained placenta for more than 60 minutes or as defined by trial author; maternal haemoglobin less than 9 g/dL at 24 to 48 hours post-delivery or blood transfusion; organ failure; intensive care unit admission; caregiver satisfaction; cost-effectiveness; evacuation of retained products; or infection.
  
  
  CONCLUSIONS
  CCT has the advantage of reducing the risk of manual removal of the placenta in some circumstances, and evidence suggests that CCT can be routinely offered during the third stage of labour, provided the birth attendant has the necessary skills. CCT should remain a core competence of skilled birth attendants. However, the limited benefits of CCT in terms of severe PPH would not justify the major investment which would be needed to provide training in CCT skills for birth attendants who do not have formal training. Women who prefer a less interventional approach to management of the third stage of labour can be reassured that when a uterotonic agent is used, routine use of CCT can be omitted from the 'active management' package without increased risk of severe PPH, but that the risk of manual removal of the placenta may be increased.Research gaps include the use of CCT in the absence of a uterotonic, and the place of uterine massage in the management of the third stage of labour.
authors: Department of Obstetrics and Gynaecology, East London Hospital Complex, University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health, Frere and Cecilia Makiwane Hospitals, Private Bag X 9047, East London, Eastern Cape, South Africa, 5200.
authors: G Justus
authors: GJ
authors: Hofmeyr
authors: Nolundi T
authors: NT
authors: Mshweshwe
authors: A Metin
authors: AM
authors: Gülmezoglu
mesh_terms: D003250:Constriction; D004874:Ergonovine / Q000008:administration & dosage; D005113:Extraction, Obstetrical / Q000379:methods; D005260:Female; D006801:Humans; D007749:Labor Stage, Third; D010120:Oxytocics / Q000008:administration & dosage; D010920:Placenta; D006473:Postpartum Hemorrhage / Q000517:prevention & control; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D014470:Umbilical Cord
chemical_list: D010120:Oxytocics; D004874:Ergonovine
references: BJOG. 2007 Jul;114(7):845-54
references: 17567419
references: Int J Gynaecol Obstet. 2009 Oct;107(1):4-7
references: 19541304
references: BJOG. 2001 Sep;108(9):898-903
references: 11563457
references: Reprod Health. 2009 Jan 21;6:2
references: 19154621
references: Lancet. 2012 May 5;379(9827):1721-7
references: 22398174
references: Br Med J. 1962 Jun 23;1(5294):1728-32
references: 13915696
references: Cochrane Database Syst Rev. 2013 Jul 11;(7):CD004074
references: 23843134
references: Cochrane Database Syst Rev. 2011 Nov 09;(11):CD007412
references: 22071837
references: J Obstet Gynaecol Can. 2003 Nov;25(11):952-5
references: 14608446
references: Cochrane Database Syst Rev. 2008 Jul 16;(3):CD004737
references: 18646109
references: Br Med J. 1963 Dec 28;2(5373):1620-3
references: 14066183
references: S Afr Med J. 1963 Sep 7;37:925-6
references: 14052570
references: Cochrane Database Syst Rev. 2012 Aug 15;(8):CD003248
references: 22895933
references: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003249
references: 17253486
references: Am J Obstet Gynecol. 1997 Oct;177(4):770-4
references: 9369817
references: Int J Gynaecol Obstet. 2014 Jan;124(1):84-5
references: 24156986
references: BJOG. 2005 Jan;112(1):89-96
references: 15663404
references: Med J Aust. 1971 Apr 24;1(17):899-903
references: 4930658
references: BMJ. 2013 Mar 28;346:f1541
references: 23538918
references: Bull World Health Organ. 2007 Apr;85(4):322-3
references: 17546315
references: Arch Gynecol Obstet. 2005 Apr;271(4):343-5
references: 15034720